InChI=1S/C29H50O4/c1-20(8-5-15-28(2,3)33)24-13-14-25-22(9-6-16-29(24,25)4)12-11-21-18-26(31)23(10-7-17-30)27(32)19-21/h11-12,20,23-27,30-33H,5-10,13-19H2,1-4H3/b21-11-,22-12+/t20-,23-,24-,25+,26-,27-,29-/m1/s1 |
OETBDAZRINTQAP-GVGIUTEISA-N |
C1[C@]2([C@](/C(=C/C=C/3\C[C@H]([C@@H]([C@@H](C3)O)CCCO)O)/CC1)(CC[C@@]2([C@H](C)CCCC(C)(C)O)[H])[H])C |
|
fat-soluble vitamin (role)
Any vitamin that dissolves in fats and are stored in body tissues. Unlike the water-soluble vitamins, they are stored in the body for long periods of time and generally pose a greater risk for toxicity when consumed in excess.
(via vitamin D )
|
|
angiogenesis modulating agent
An agent that modulates the physiologic angiogenesis process. This is accomplished by endogenous angiogenic proteins and a variety of other chemicals and pharmaceutical agents.
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
(1R,2S,3R,5Z,7E,17β)-17-[(2R)-6-hydroxy-6-methylheptan-2-yl]-2-(3-hydroxypropyl)-9,10-secoestra-5,7-diene-1,3-diol
|
(5Z,7E)-(1R,2S,3R)-3-(hydroxypropyl)-19-nor-9,10-seco-5,7-cholestadien-1,3,25-triol
|
ChEBI
|
MART-10
|
ChEBI
|
9533244
|
Reaxys Registry Number
|
Reaxys
|
21888924
|
PubMed citation
|
Europe PMC
|
22982757
|
PubMed citation
|
Europe PMC
|
23157238
|
PubMed citation
|
Europe PMC
|
23304196
|
PubMed citation
|
Europe PMC
|
23549173
|
PubMed citation
|
Europe PMC
|
24044969
|
PubMed citation
|
Europe PMC
|
24125734
|
PubMed citation
|
Europe PMC
|
25149065
|
PubMed citation
|
Europe PMC
|
25918960
|
PubMed citation
|
Europe PMC
|
26282787
|
PubMed citation
|
Europe PMC
|
26385607
|
PubMed citation
|
Europe PMC
|
|